Mechanisms of DMP Development and Atrioventricular Septation

DMP 发生和房室间隔的机制

基本信息

  • 批准号:
    8903571
  • 负责人:
  • 金额:
    $ 37.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-01 至 2015-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Atrioventricular septal defects (AVSDs) are congenital heart malformations found in approximately 5% of all individuals suffering from congenital heart disease (CHD). They are particularly common in individuals with Down Syndrome (DS) and in patients with heterotaxy syndrome. While it was believed for many years that abnormal development of atrioventricular cushions was the only mechanism involved in the pathogenesis of these defects, more recent studies have revealed that perturbation of tissues derived from the posterior Second Heart Field (pSHF) located at the venous pole of the heart, including the primary atrial septum and the Dorsal Mesenchymal Protrusion (DMP), play a critical role in the pathogenesis of AVSDs as well. In this application we propose to investigate the synergistic relationship between three signaling pathways that are involved in the regulation of pSHF/DMP development and in the formation of the AV septal complex, i.e. the Hedgehog (Hh) signaling pathway, the Wnt(2)/�-catenin pathway, and the BMP signaling pathway. Some of the molecular mechanisms implicated in pathogenesis of AVSDs are also involved in the assembly and/or function of primary cilia, which, as we have established, are also present on pSHF cells. The fact that abnormalities in the function and/or structure of cilia are associated with the pathogenesis of AVSDs, in combination with a series of observations and preliminary results outlined in the proposal, has led to the overarching hypothesis that the Wnt/�-catenin and BMP signaling pathways in the pSHF are part of a complex molecular network orchestrating the development of the pSHF and are located down-stream of the cilia-associated Shh pathway.
描述(由申请人提供):房室间隔缺陷(AVSD)是一种先天性心脏畸形,约占所有先天性心脏病(CHD)患者的5%。它们在唐氏综合征(DS)患者和异位综合征患者中尤其常见。虽然多年来一直认为房室垫发育异常是房室间隔发育异常的唯一机制,但最近的研究表明,位于心脏静脉极的后第二心场(PSHF)组织的扰动,包括初级房间隔和背侧间充质突出(DMP),在AVSD的发病中也起着关键作用。在这一应用中,我们建议研究参与调控pSHF/DMP发育和房室间隔复合体形成的三个信号通路之间的协同关系,即Hedgehog(HH)信号通路、Wnt(2)/�-catenin通路和BMP信号通路。一些与AVSD发病相关的分子机制也涉及初生纤毛的组装和/或功能,正如我们已经确定的,初生纤毛也存在于pSHF细胞中。纤毛功能和/或结构的异常与aVSD的发病机制有关,结合本研究中概述的一系列观察和初步结果,导致了一个重要的假设,即pSHF中的Wnt/�-catenin和BMP信号通路是协调pSHF发展的复杂分子网络的一部分,位于纤毛相关Shh通路的下游。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Arno Wessels其他文献

Arno Wessels的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Arno Wessels', 18)}}的其他基金

Exploring the Role of the anterior SHF in AVSD Pathogenesis
探索前 SHF 在 AVSD 发病机制中的作用
  • 批准号:
    10854097
  • 财政年份:
    2023
  • 资助金额:
    $ 37.38万
  • 项目类别:
Role of the Epicardium in Valve Development and Valve Disease
心外膜在瓣膜发育和瓣膜疾病中的作用
  • 批准号:
    10597222
  • 财政年份:
    2022
  • 资助金额:
    $ 37.38万
  • 项目类别:
Role of the Epicardium in Valve Development and Valve Disease
心外膜在瓣膜发育和瓣膜疾病中的作用
  • 批准号:
    10418935
  • 财政年份:
    2022
  • 资助金额:
    $ 37.38万
  • 项目类别:
Mechanisms of DMP Development and Atrioventricular Septation
DMP 发生和房室间隔的机制
  • 批准号:
    8885266
  • 财政年份:
    2015
  • 资助金额:
    $ 37.38万
  • 项目类别:
Mechanisms of DMP Development and Atrioventricular Septation
DMP 发生和房室间隔的机制
  • 批准号:
    10158501
  • 财政年份:
    2014
  • 资助金额:
    $ 37.38万
  • 项目类别:
Mechanisms of DMP Development and Atrioventricular Septation
DMP 发生和房室间隔的机制
  • 批准号:
    10614559
  • 财政年份:
    2014
  • 资助金额:
    $ 37.38万
  • 项目类别:
Mechanisms of DMP Development and Atrioventricular Septation
DMP 发生和房室间隔的机制
  • 批准号:
    10459249
  • 财政年份:
    2014
  • 资助金额:
    $ 37.38万
  • 项目类别:
Mechanisms of DMP Development and Atrioventricular Septation
DMP 发生和房室间隔的机制
  • 批准号:
    9973618
  • 财政年份:
    2014
  • 资助金额:
    $ 37.38万
  • 项目类别:
The Role of Cartilage Link Protein 1 (Crtl1) in Heart Development
软骨连接蛋白 1 (Crtl1) 在心脏发育中的作用
  • 批准号:
    7589793
  • 财政年份:
    2007
  • 资助金额:
    $ 37.38万
  • 项目类别:
The Role of Cartilage Link Protein 1 (Crtl1) in Heart Development
软骨连接蛋白 1 (Crtl1) 在心脏发育中的作用
  • 批准号:
    7199417
  • 财政年份:
    2007
  • 资助金额:
    $ 37.38万
  • 项目类别:

相似海外基金

Mechanisms of cell proliferation in whole-genome doubled cells
全基因组加倍细胞的细胞增殖机制
  • 批准号:
    10467183
  • 财政年份:
    2022
  • 资助金额:
    $ 37.38万
  • 项目类别:
Mechanisms of cell proliferation in whole-genome doubled cells
全基因组加倍细胞的细胞增殖机制
  • 批准号:
    10612928
  • 财政年份:
    2022
  • 资助金额:
    $ 37.38万
  • 项目类别:
Mechanisms of cell proliferation in whole-genome doubled cells
全基因组加倍细胞的细胞增殖机制
  • 批准号:
    10796612
  • 财政年份:
    2022
  • 资助金额:
    $ 37.38万
  • 项目类别:
Mechanisms of Cell proliferation and tumorigenesis in ATP1A1 gene mutated adrenal cells
ATP1A1基因突变肾上腺细胞增殖及肿瘤发生机制
  • 批准号:
    21K16058
  • 财政年份:
    2021
  • 资助金额:
    $ 37.38万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Invesitigation of GLP-1 mediated pancreatic beta cell proliferation by interactions between islets and acinar cells
通过胰岛和腺泡细胞之间的相互作用研究 GLP-1 介导的胰腺 β 细胞增殖
  • 批准号:
    20K17516
  • 财政年份:
    2020
  • 资助金额:
    $ 37.38万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Engineering synthetic helper cells that autonomously deliver orthogonal IL-2 to selectively promote therapeutic T cell proliferation in tumors
工程合成辅助细胞可自主递送正交 IL-2 以选择性促进肿瘤中治疗性 T 细胞增殖
  • 批准号:
    10285941
  • 财政年份:
    2019
  • 资助金额:
    $ 37.38万
  • 项目类别:
HEG1-responsive microRNA-23b regulates cell proliferation in malignant mesothelioma cells
HEG1 反应性 microRNA-23b 调节恶性间皮瘤细胞的细胞增殖
  • 批准号:
    19K07439
  • 财政年份:
    2019
  • 资助金额:
    $ 37.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Temporal information coding of cell proliferation inhibitory signal revealed by optical measurement and control of p38 activity in living cells
通过活细胞中 p38 活性的光学测量和控制揭示细胞增殖抑制信号的时间信息编码
  • 批准号:
    19K06548
  • 财政年份:
    2019
  • 资助金额:
    $ 37.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the mechanism of platelet-activating factor (PAF)-associated cell proliferation in cancer and non-cancer cells.
阐明癌症和非癌细胞中血小板激活因子(PAF)相关细胞增殖的机制。
  • 批准号:
    19K10305
  • 财政年份:
    2019
  • 资助金额:
    $ 37.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of novel MMP-3 degrading products and investigation of cell proliferation using high purity odontoblast-like cells
使用高纯度成牙本质细胞样细胞鉴定新型 MMP-3 降解产物并研究细胞增殖
  • 批准号:
    15K20418
  • 财政年份:
    2015
  • 资助金额:
    $ 37.38万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了